Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Revenue (2017 - 2025)

Assembly Biosciences has reported Revenue over the past 8 years, most recently at $42.5 million for Q4 2025.

  • Quarterly results put Revenue at $42.5 million for Q4 2025, up 477.26% from a year ago — trailing twelve months through Dec 2025 was $72.3 million (up 153.52% YoY), and the annual figure for FY2025 was $72.3 million, up 153.52%.
  • Revenue for Q4 2025 was $42.5 million at Assembly Biosciences, up from $10.8 million in the prior quarter.
  • Over the last five years, Revenue for ASMB hit a ceiling of $42.5 million in Q4 2025 and a floor of $5.8 million in Q1 2024.
  • Median Revenue over the past 4 years was $7.9 million (2024), compared with a mean of $11.4 million.
  • Biggest five-year swings in Revenue: plummeted 81.93% in 2021 and later skyrocketed 477.26% in 2025.
  • Assembly Biosciences' Revenue stood at $6.3 million in 2021, then rose by 14.53% to $7.2 million in 2023, then rose by 2.71% to $7.4 million in 2024, then skyrocketed by 477.26% to $42.5 million in 2025.
  • The last three reported values for Revenue were $42.5 million (Q4 2025), $10.8 million (Q3 2025), and $9.6 million (Q2 2025) per Business Quant data.